Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bluejay Diagnostics (BJDX) Cash from Operations (2022 - 2023)

Bluejay Diagnostics' Cash from Operations history spans 2 years, with the latest figure at 2777477.0 for Q4 2023.

  • For Q4 2023, Cash from Operations rose 5.66% year-over-year to 2777477.0; the TTM value through Dec 2023 reached 8313870.0, down 7.39%, while the annual FY2024 figure was 7819769.0, 5.94% up from the prior year.
  • Cash from Operations for Q4 2023 was 2777477.0 at Bluejay Diagnostics, down from 1125066.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 1125066.0 in Q3 2023 and bottomed at 2944243.0 in Q4 2022.